One News
Subscribe
Breaking · 2 sources

Just broke · 2 sources · 1h ago

Eli Lilly Obesity Pill Foundayo Reduces Sleep Apnea Symptoms in Late-Stage Trials

Eli Lilly & Co. reported that its weight loss pill Foundayo effectively controlled sleep apnea in clinical studies, leading the company to plan for a U.S. regulatory filing by the end of the year.

Reported by 2 outlets1 framings1h ago

Coverage spectrum

2 sources · L 0 · C 2 · R 0

  • S&P 5007,538.33+2.19%Nov 9, 11:01 AM
  • Nasdaq 10027,877.15+3.29%Nov 9, 11:01 AM
  • Dow52,207.52+1.80%Nov 9, 11:01 AM
  • Russell 20002,823.27+2.51%Nov 9, 11:01 AM
  • VIX20.54−19.90%Nov 9, 11:01 AM
  • S&P futures7,553.25+2.04%Nov 9, 10:51 AM
  • Nasdaq futures27,925.75+3.10%Nov 9, 10:51 AM
  • Crude oil88.16−2.94%Nov 9, 10:51 AM
  • Gold4,129.30+1.34%Nov 9, 10:51 AM
  • 10-yr note106.95−0.15%Nov 9, 10:51 AM
  • EUR/USD1.1196+0.43%Nov 9, 11:01 AM
  • USD/JPY158.1160−0.11%Nov 9, 11:01 AM
  • GBP/USD1.3403+0.32%Nov 9, 11:01 AM
  • USD/CNH6.6710−0.01%Nov 9, 11:01 AM

Read at your length

Eli Lilly & Co. reported that its weight loss pill Foundayo effectively controlled sleep apnea in clinical studies, leading the company to plan for a U.S. regulatory filing by the end of the year.

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. Eli Lilly & Co.’s weight loss pill Foundayo helped control sleep apnea in two large trials, reducing nighttime disruptions for patients and paving the way for a new use for the daily drug.

CNBC reported the story as "Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval."

2 sources have covered this story, including CNBC and Bloomberg. The earliest reporting in the cluster landed about 1 hour ago.

How each side is reporting it

2 outlets · 1 sides · comparison ready

Left0 outlets

How the left is reporting it

No coverage from this side yet.

Center2 outlets

How the wires + center are reporting it

Right0 outlets

How the right is reporting it

No coverage from this side yet.

Where sources agree

No shared facts cached yet.

Where they diverge

No contradictions cached yet.

How it spread

Bloomberg reported it first, Nov 9, 9:30 AM ET. All 2 outlets carried it within the same minute, all in the center.All in the United States.

Left 0Center 2Right 0No left or right outlets yet.

Time since the first report

Who carried it, in order

  1. FirstBloombergNov 9, 9:30 AM ETCenter
  2. +0mCNBCNov 9, 9:30 AM ETCenter

Claim ledger

Atomic claims · cross-source evidence graph

How we verify →
  1. [01]
    Verified

    Core event reported by 2 independent outlets across the spectrum.

    2 corroborating · 1 primary-source link

  2. [02]
    Disputed

    Key facts present in mainstream desks; corroboration thin from wires.

    2 corroborating

Framings — how each side is covering it

All sources covering this story

Source registry →